Atencion primaria
-
Randomized Controlled Trial Clinical Trial
[Continuing medical education about the use of antilipemic agents in elderly patients aged 65-75 years].
The objective is evaluating the efficacy of the educative intervention to primary care physicians, about the accurate dyslipidaemia management in population between 65 and 75 years old with hypercholesterolemia. ⋯ The educative session to primary care physicians reinforced with the shipment of the received information, is not likely to relieve the criteria fulfillment rate of accurate management of population between 65 and 75 years old with hypercholesterolemia.
-
Randomized Controlled Trial Clinical Trial
[Cost-effectiveness of atorvastatin against simvastatin as hypolipemic treatment in hypercholesterolemic patients in primary care].
To perform an economics evaluation of lipid-lowering therapy with atorvastatin and simvastatin in patients with hypercholesterolemia in primary care setting. ⋯ Both statins were effective as lipid-lowering agents. However, atorvastatin 10 mg was more efficient than simvastatin 20 mg due to a better cost-effectiveness ratio.
-
Randomized Controlled Trial Clinical Trial
[Design of a method for the evaluation of clinical competence in primary care].
To measure clinical competence in primary care (PC). ⋯ The use of SP is a good method of evaluation, as it enables anamnesis, management of the patient, physical examination and communication to be assessed. The study is very reliable, with low reproduction, which is probably due to the few cases used.
-
Randomized Controlled Trial Clinical Trial
[Treatment compliance in arterial hypertension. A 2-year intervention trial through health education].
To analyse the efficacy of health education (HE) through a group session with two years of intervention by postal back-up on compliance with therapy for light-to-moderate essential hypertension. ⋯ HE intervention is an effective measure to improve therapeutic compliance in essential hypertension and lasts for up to two years.
-
Randomized Controlled Trial Comparative Study Clinical Trial
[Coronary risk and prescription in primary care patients with hypercholesterolemia].
In patients with hypercholesterolaemia determinate the prevalence of high coronary risk (CR), study the lipid lowering treatment applied and determinate if there is any change in CR after a period of treatment. ⋯ Applying the Framingham coronary multivariate risk method we estimate high CR > 20%. Patients with a previous history of cardiovascular event, were treated in a 50%, more frequently younger subjects, rising 220 mg/dl of final cholesterol level. Patients without any cardiovascular event known, the 32.5% (28.0-36.7%) have a CR > 20%. Subjects with high CR have 4.9 (3.0-8.2) more probability if receiving treatment than the others with lower risk. The lipid-lowering treatment is explained in a 67% because the high CR and the family history of coronary event. After at least one year period there is a reduction in those with high CR (difference relative of proportions 28.7% [20.4-37.1]).